Home/Investors/NovaQuest Capital Management

NovaQuest Capital Management

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$2.1B
Focus Areas
6
Top Stage
Approved

Portfolio Companies

CompanyValuation
Mesoblast$2.1B
Mycovia Pharmaceuticals

Frequent Co-Investors